Europe Dry Eye Products Market Forecast to 2031

At 4.6% CAGR, Europe Dry Eye Products Market is Projected to be Worth US$ 2,311.60 Million by 2031, says The Research team

According to The Research team’ research, the Europe dry eye products market was valued at US$ 1,617.59 million in 2023 and is expected to reach US$ 2,311.60 million by 2031, registering a CAGR of 4.6% from 2023 to 2031. Increasing initiatives for eye care awareness and ongoing research and growing pipeline for dry eye products are among the critical factors attributed to drive the Europe dry eye products market growth.

In recent years, various initiatives have been taken to create awareness and educate people regarding eye diseases, prompting patients to access suitable medications and treatments. ABP focuses on moderate to severe vision damage caused by glaucoma and retinal conditions that are responsible for a large proportion of preventable blindness.

The International Agency for the Prevention of Blindness (IAPB) launched the global campaign named “Love Your Eyes” in 2022 to raise awareness of the socioeconomic importance of eye health. The campaign calls upon governments and global institutions to support eye health. The IAPB emphasizes programs and initiatives in India and the world, which promptly focus on offering accessible, available, and affordable eye care. The “Love Your Eyes” program also calls for regulation changes and funding to make eye care accessible, available, and affordable by 2030.

The Karolinska Institute, Sweden, offers grants to promote research on eye diseases. In 2020, the institute announced US$ 5,900–17,000 (SEK 50,000–150,000) per person to fund new research projects on eye diseases.

Thus, increasing funds for eyecare research and rising initiatives to spread awareness about eye care are likely to create new opportunities in the dry eye product market in the coming years.

On the contrary, side effects of eye drops and product recalls hamper the growth of Europe dry eye products market.

Based on product, the Europe dry eye products market is segmented into artificial tears, anti-inflammatory drugs, punctal plugs, secretagogues, oral omega supplements, and others. The artificial tears segment held 47.8% market share in 2023, amassing US$ 773.65 million. It is projected to garner US$ 1,121.23 million by 2031 to register 4.8% CAGR during 2023–2031. Furthermore, the anti-inflammatory drugs segment is subcategorized into cyclosporine, corticosteroid, and others. Additionally, the punctal plugs segment is subsegmented into dissolvable and removable.

In terms of dosage form, the Europe dry eye products market is segmented into eye drops, gel, capsules and tablets, and others. The eye drops segment held 64.8% share Europe dry eye products market in 2023, amassing US$ 1,048.37 million. It is anticipated to garner US$ 1,525.41 million by 2031 to expand at 4.8% CAGR during 2023–2031.

By type, the Europe dry eye products market is bifurcated into OTC and prescription. The OTC segment held 57.7% share of Europe dry eye products market in 2023, amassing US$ 933.97 million. It is projected to garner US$ 1,372.74 million by 2031 to expand at 4.9% CAGR from 2023 to 2031.

Based on distribution channel, the Europe dry eye products market is categorized into retail pharmacy, hospital pharmacy, and online pharmacy. The retail pharmacy segment held 46.0% share of Europe dry eye products market in 2023, amassing US$ 744.81 million. It is predicted to garner US$ 1,059.32 million by 2031 to expand at 4.5% CAGR between 2023 and 2031.

Based on country, the Europe dry eye products market is categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 26.5% share of Europe dry eye products market in 2023. It was assessed at US$ 428.69 million in 2023 and is likely to hit US$ 620.92 million by 2031, registering a CAGR of 4.7% during 2023–2031.

Key players operating in the Europe dry eye products market are Santen Pharmaceutical Co Ltd, Johnson & Johnson, OASIS Medical, URSAPHARM Arzneimittel GmbH, Rohto Pharmaceutical Co Ltd, OCuSOFT Inc, Bausch Health Companies Inc, AbbVie Inc, Prestige Consumer Healthcare Inc, Farmigea SpA, and Alcon AG, among others.

In September 2023, Bausch + Lomb Corporation (“Bausch + Lomb”), a subsidiary of Bausch Health Companies Inc completed its acquisition of XIIDRA (lifitegrast ophthalmic solution) 5%, a non- steroid eye drop specifically approved to treat the signs and symptoms of dry eye disease focusing on inflammation associated with dry eye, and certain other ophthalmology assets.
In April 2021, MY OASIS is a cyber platform that allows eye care practitioners to grow their brand as a dry eye resource, broaden the reach of their practice, and provide access to solutions that can improve the quality of life for dry eye patients in their region. Its simple and intuitive design ensures a pleasant user experience.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe dry eye products market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Europe dry eye products market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the dry eye products market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Dry Eye Products Market – Key Market Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Dry Eye
4.1.2 Upsurge in Geriatric Population
4.2 Market Restraints
4.2.1 Side Effects of Eye Drops and Product Recalls
4.3 Market Opportunities
4.3.1 Increasing Initiatives for Eye Care Awareness
4.4 Future Trends
4.4.1 Ongoing Research and Growing Pipeline for Dry Eye Products
4.5 Impact of Drivers and Restraints:
5. Dry Eye Products Market – Europe Market Analysis
5.1 Europe Dry Eye Products Market Revenue (US$ Million), 2021–2031
6. Europe Dry Eye Products Market Analysis – by Product
6.1 Overview
6.2 Artificial Tears
6.2.1 Overview
6.2.2 Artificial Tears: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
6.3 Anti-Inflammatory Drugs
6.3.1 Overview
6.3.2 Anti-Inflammatory Drugs: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
6.3.2.1 Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Anti-inflammatory Drugs
6.4 Punctal Plugs
6.4.1 Overview
6.4.2 Punctal Plugs: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
6.4.2.1 Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Punctal Plugs
6.5 Secretagogues
6.5.1 Overview
6.5.2 Secretagogues: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
6.6 Oral Omega Supplements
6.6.1 Overview
6.6.2 Oral Omega Supplements: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7. Europe Dry Eye Products Market Analysis – by Dosage Form
7.1 Overview
7.2 Eye Drops
7.2.1 Overview
7.2.2 Eye Drops: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Gels
7.3.1 Overview
7.3.2 Gels: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Capsules and Tablets
7.4.1 Overview
7.4.2 Capsules and Tablets: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Dry Eye Products Market Analysis – by Type
8.1 Overview
8.2 OTC
8.2.1 Overview
8.2.2 OTC: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Prescription
8.3.1 Overview
8.3.2 Prescription: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
9. Europe Dry Eye Products Market Analysis – by Distribution Channel
9.1 Overview
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Online Pharmacies
9.4.1 Overview
9.4.2 Online Pharmacies: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10. Europe Dry Eye Products Market – Country Analysis
10.1 Europe: Dry Eye Products Market
10.1.1 Europe: Dry Eye Products Market – Revenue and Forecast Analysis – by Country
10.1.1.1 Germany: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.1.1 Germany: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.1.2 Germany: Dry Eye Products Market Breakdown, by Product
10.1.1.1.2.1 Germany: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.1.2.2 Germany: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.1.3 Germany: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.1.4 Germany: Dry Eye Products Market Breakdown, by Type
10.1.1.1.5 Germany: Dry Eye Products Market Breakdown, by Distribution Channel
10.1.1.2 United Kingdom: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 United Kingdom: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.2.3 United Kingdom: Dry Eye Products Market Breakdown, by Product
10.1.1.2.3.1 United Kingdom: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.2.3.2 United Kingdom: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.2.4 United Kingdom: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.2.5 United Kingdom: Dry Eye Products Market Breakdown, by Type
10.1.1.2.6 United Kingdom: Dry Eye Products Market Breakdown, by Distribution Channel
10.1.1.3 France: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 France: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.3.3 France: Dry Eye Products Market Breakdown, by Product
10.1.1.3.3.1 France: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.3.3.2 France: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.3.4 France: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.3.5 France: Dry Eye Products Market Breakdown, by Type
10.1.1.3.6 France: Dry Eye Products Market Breakdown, by Distribution Channel
10.1.1.4 Italy: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.4.3 Italy: Dry Eye Products Market Breakdown, by Product
10.1.1.4.3.1 Italy: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.4.3.2 Italy: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.4.4 Italy: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.4.5 Italy: Dry Eye Products Market Breakdown, by Type
10.1.1.4.6 Italy: Dry Eye Products Market Breakdown, by Distribution Channel
10.1.1.5 Spain: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.5.3 Spain: Dry Eye Products Market Breakdown, by Product
10.1.1.5.3.1 Spain: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.5.3.2 Spain: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.5.4 Spain: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.5.5 Spain: Dry Eye Products Market Breakdown, by Type
10.1.1.5.6 Spain: Dry Eye Products Market Breakdown, by Distribution Channel
10.1.1.6 Rest of Europe: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.6.3 Rest of Europe: Dry Eye Products Market Breakdown, by Product
10.1.1.6.3.1 Rest of Europe: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.6.3.2 Rest of Europe: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.6.4 Rest of Europe: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.6.5 Rest of Europe: Dry Eye Products Market Breakdown, by Type
10.1.1.6.6 Rest of Europe: Dry Eye Products Market Breakdown, by Distribution Channel
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Dry Eye Products Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Santen Pharmaceutical Co Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Johnson & Johnson
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 OASIS Medical
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 URSAPHARM Arzneimittel GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Rohto Pharmaceutical Co Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 OCuSOFT Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bausch Health Companies Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 AbbVie Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Prestige Consumer Healthcare Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Farmigea SpA
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Alcon AG
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About The Research Team
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Dry Eye Products Market Segmentation
Table 2. Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Anti-inflammatory Drugs
Table 3. Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Punctal Plugs
Table 4. Germany: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 5. Germany: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Anti-inflammatory Drugs
Table 6. Germany: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Punctal Plugs
Table 7. Germany: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 8. Germany: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 9. Germany: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Distribution Channel
Table 10. United Kingdom: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 11. United Kingdom: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Anti-inflammatory Drugs
Table 12. United Kingdom: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Punctal Plugs
Table 13. United Kingdom: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 14. United Kingdom: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 15. United Kingdom: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Distribution Channel
Table 16. France: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 17. France: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Anti-inflammatory Drugs
Table 18. France: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Punctal Plugs
Table 19. France: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 20. France: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 21. France: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Distribution Channel
Table 22. Italy: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 23. Italy: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Anti-inflammatory Drugs
Table 24. Italy: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Punctal Plugs
Table 25. Italy: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 26. Italy: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 27. Italy: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Distribution Channel
Table 28. Spain: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 29. Spain: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Anti-inflammatory Drugs
Table 30. Spain: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Punctal Plugs
Table 31. Spain: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 32. Spain: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 33. Spain: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Distribution Channel
Table 34. Rest of Europe: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 35. Rest of Europe: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Anti-inflammatory Drugs
Table 36. Rest of Europe: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Punctal Plugs
Table 37. Rest of Europe: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 38. Rest of Europe: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 39. Rest of Europe: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Distribution Channel
Table 40. Recent Organic Growth Strategies in the Dry Eye Products Market
Table 41. Recent Inorganic Growth Strategies in the Dry Eye Products Market
Table 42. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Dry Eye Products Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Europe Dry Eye Products Market Revenue (US$ Million), 2021–2031
Figure 4. Dry Eye Products Market Share (%) – by Product (2023 and 2031)
Figure 5. Artificial Tears: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 6. Anti-Inflammatory Drugs: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Punctal Plugs: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Secretagogues: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Oral Omega Supplements: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Others: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Europe Dry Eye Products Market Share (%) – by Dosage Form (2023 and 2031)
Figure 12. Eye Drops: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Gels: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Capsules and Tablets: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Others: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Dry Eye Products Market Share (%) – by Type (2023 and 2031)
Figure 17. OTC: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Prescription: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Dry Eye Products Market Share (%) – by Distribution Channel (2023 and 2031)
Figure 20. Retail Pharmacies: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Hospital Pharmacies: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Online Pharmacies: Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Europe: Dry Eye Products Market, by Key Country – Revenue (2023) (US$ Million)
Figure 24. Europe: Dry Eye Products Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 25. Germany: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 26. United Kingdom: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 27. France: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 28. Italy: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 29. Spain: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 30. Rest of Europe: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
Figure 31. Growth Strategies in the Dry Eye Products Market